se of Bone Morphogenic Protein 7 in the atrophic maxilla - CH. MAX-FACC 01/2007
- Conditions
- bone atrophy of the maxillaMedDRA version: 6.1Level: PTClassification code 10031248
- Registration Number
- EUCTR2007-002123-32-IT
- Lead Sponsor
- AZIENDA OSPEDALIERA DI BOLOGNA POLICLINICO S. ORSOLA M. MALPIGHI
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Authorised-recruitment may be ongoing or finished
- Sex
- All
- Target Recruitment
- Not specified
Inclusion Criteria
Patients who need bilateral sinus lift for implant rehabilitation
Male or Female over the age of 18
Patients without sinus deseases or other invalidate deasease
Are the trial subjects under 18? no
Number of subjects for this age range:
F.1.2 Adults (18-64 years) yes
F.1.2.1 Number of subjects for this age range
F.1.3 Elderly (>=65 years) no
F.1.3.1 Number of subjects for this age range
Exclusion Criteria
Tobacco abuse
Women pregnant
Diabetes
Known hypersensibility towards trial drug or collagen
Concomitant use of Biphosphonates
Study & Design
- Study Type
- Interventional clinical trial of medicinal product
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Main Objective: Implant survival and success, sinus lifted bone histologic and histomorphometic evaluation 4 month after surgery;Secondary Objective: Sinus lifted bone gain evaluation, sinus lifted bone resorption;Primary end point(s): Implant survival and success, sinus lifted bone histologic and histomorphometic evaluation 4 month after surgery.
- Secondary Outcome Measures
Name Time Method